product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
other
product name :
Human Seroblock
catalog :
BUF070A
quantity :
50 Test
price :
152 USD
more info or order :
image
image 1 :
Bio-Rad BUF070A image 1
Staining of THP-1 cells with FITC labelled Mouse anti Human CD11a ( MCA1848 ) or Mouse IgG2a Negative Control:FITC ( MCA929F ) in the absence (A) and presence (B) of Human SeroBlock ( BUF070A ). Antibody and isotype control were both used neat. Blue shaded areas represents cells stained with the CD11a antibody while the clear areas represents cells stained with isotype control
product information
Entity Type :
Accessory Reagent
Entity Category :
Other Reagents
ProductCode :
BUF070A
Description :
Human Seroblock
Specificity :
Human Seroblock
TargetSpecies :
Human
Format :
Reagent
Applications :
F
ApplicationTypes :
Flow Cytometry
Quantity :
50 Test
Quantity Value :
50
Quantity Type :
Test
Entity Formats :
Reagent
UNSPSC :
41116126
PriceGBP :
108
PriceEUR :
152
PriceUSD :
152 USD
PriceCHF :
165
PriceSEK :
1657
PriceNOK :
1665
PriceDKK :
1133
NotForSaleInCountries :
KR ,CN
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.